ResMed Inc. vs. Sight Sciences, Inc. Common Stock
ResMed Inc. (RMD) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| RMD | SGHT | |
|---|---|---|
| Market Cap | $30.74 billion | $411.51 million |
| Revenue (TTM) | $5.54 billion | $83.38 million |
| Net Income (TTM) | $1.52 billion | $-29,757,000 |
RMD leads on 3 of 3 size & scale factors.
Valuation
| RMD | SGHT | |
|---|---|---|
| P/E Ratio | 20.44 | — |
| Price / Book | 4.74 | 7.78 |
| Price / Sales | 5.55 | 4.94 |
RMD and SGHT split the valuation factors evenly.
Profitability
| RMD | SGHT | |
|---|---|---|
| Net Margin | 27.44% | -35.69% |
| Return on Equity | 23.41% | -56.26% |
RMD leads on 2 of 2 profitability factors.
Dividend
| RMD | SGHT | |
|---|---|---|
| Dividend Yield | 1.25% | — |
| Payout Ratio | 25.46 | — |
RMD and SGHT split the dividend factors evenly.
Risk & Sentiment
| RMD | SGHT | |
|---|---|---|
| Short Interest | 4.02% | 0.44% |
SGHT leads on 1 of 1 risk & sentiment factors.
Dig deeper: RMD overview, RMD financials, SGHT overview, SGHT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.